BioHarvest Sciences Inc. Files September 2025 6-K Report

Ticker: BHST · Form: 6-K · Filed: Sep 9, 2025

Sentiment: neutral

Topics: sec-filing, 6-k, regulatory-update

Related Tickers: BHSC

TL;DR

BHSC filed its monthly 6-K report, confirming its status as a foreign private issuer and its compliance with US securities laws.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on September 9, 2025, reporting for the month of September 2025. The company, previously known as Canna-V-Cell Sciences Inc. and Midnight Star Ventures Corp., is incorporated in Canada and operates in the Pharmaceutical Preparations sector. This filing is made under the Securities Exchange Act of 1934.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s regulatory reporting status for September 2025, indicating ongoing compliance with SEC requirements for foreign private issuers.

Risk Assessment

Risk Level: low — This is a routine monthly filing (6-K) that primarily confirms the company's reporting status and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report for the month of September 2025 as a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What is BioHarvest Sciences Inc.'s SEC file number?

BioHarvest Sciences Inc.'s SEC file number is 001-42389.

What are the former names of BioHarvest Sciences Inc.?

BioHarvest Sciences Inc. was formerly known as Canna-V-Cell Sciences Inc. (name change effective October 8, 2019) and Midnight Star Ventures Corp. (name change effective November 21, 2017).

Where is BioHarvest Sciences Inc. located?

BioHarvest Sciences Inc.'s principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Does BioHarvest Sciences Inc. file an annual report on Form 20-F or Form 40-F?

BioHarvest Sciences Inc. files its annual reports under cover of Form 40-F.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2025-09-08 17:39:10

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: September 8, 2025 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing